Litigation Details for Alembic Pharmaceuticals Limited v. Daiichi Sankyo Co., Ltd. (N.D. Ill. 2016)
✉ Email this page to a colleague
Alembic Pharmaceuticals Limited v. Daiichi Sankyo Co., Ltd. (N.D. Ill. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-04-01 |
Court | District Court, N.D. Illinois | Date Terminated | 2016-10-03 |
Cause | 35:145 Patent Infringement | Assigned To | Rebecca R. Pallmeyer |
Jury Demand | Referred To | ||
Patents | 6,878,703 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Alembic Pharmaceuticals Limited v. Daiichi Sankyo Co., Ltd.
Details for Alembic Pharmaceuticals Limited v. Daiichi Sankyo Co., Ltd. (N.D. Ill. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-07-25 | 84 | owns certain patents, including United States Patent No. 6,878,703 ("the '703 patent"), concerning… Compl. for Decl. J. of Patent Non-infringement of U.S. Patent No. 6,878,703 [1] ΒΆ 94, Alembic, No. 16…. for Summ. J. of Noninfringement of U.S. Patent 6,878,703 [41] at 1.) In the alternative, they argue…infringe the '703 patent because Defendants have already disclaimed the patent. Mylan has filed a motion…requiring applicants to list patents "with respect to which a claim of patent infringement could reasonably | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |